Evidence map›Paper›PMID 29444633›Full record

ArticleVeterinary pathology2018

Talaromycosis (Penicilliosis) in a Cynomolgus Macaque.

William O Iverson, Subramanya Karanth, Angela Wilcox, Cau D Pham, Shawn R Lockhart, Simone M Nicholson

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Veterinary pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

William O Iverson1 MedImmune LLC, One MedImmune Way, Gaithersburg, MD, USA.
Subramanya Karanth1 MedImmune LLC, One MedImmune Way, Gaithersburg, MD, USA.
Angela Wilcox2 Charles River Laboratories, Preclinical Services, Nevada, Reno, NV, USA.
Cau D Pham3 Division of Foodborne, Waterborne and Environmental Disease, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Disease, Mycotic Diseases Branch, Fungal Reference Unit, Atlanta, GA, USA.
Shawn R Lockhart3 Division of Foodborne, Waterborne and Environmental Disease, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Disease, Mycotic Diseases Branch, Fungal Reference Unit, Atlanta, GA, USA.
Simone M Nicholson1 MedImmune LLC, One MedImmune Way, Gaithersburg, MD, USA.
Centers for Disease Control and Prevention · USCharles River Laboratories (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A sexually mature Chinese-origin female Macaca fascicularis assigned to the high-dose group in a 26-week toxicology study with an experimental immunomodulatory therapeutic antibody (a CD40 L antagonist fusion protein) was euthanized at the scheduled terminal sacrifice on study day 192. The animal was healthy at study initiation and remained clinically normal throughout the study. On study day 141, abnormal clinical pathology changes were found during a scheduled evaluation; splenomegaly was detected on study day 149 and supported by ultrasound examination. At the scheduled necropsy, there was marked splenomegaly with a nodular and discolored appearance. Cytologic examination of a splenic impression smear revealed yeast-like organisms within macrophages. Histologically, there was disseminated systemic granulomatous inflammation with 2- to 3-μm oval, intracytoplasmic yeast-like organisms in multiple organs identified as Talaromyces (Penicillium) marneffei. This organism, not previously reported as a pathogen in macaques, causes an important opportunistic infection in immunosuppressed humans in specific global geographic locations.

Indexed as

AnimalsFemaleImmunocompromised HostMacaca fascicularisMacrophagesMonkey DiseasesMycosesOpportunistic InfectionsPenicilliumTalaromycesfungusimmunosuppressionMacaca fascicularisTalaromyces (Penicillium) marneffei

Identifiers

PMID29444633
PMCPMC11900905
OpenAlexW2792107176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.